Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens.

Gudrun Würthwein; Thomas Klingebiel; Sebastian Krümpelmann; Melanie Metz; Kerstin Schwenker; Karen Kranz; Claudia Lanvers; Joachim Boos

doi:10.1097/00001813-200201000-00012

Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens.

Gudrun Würthwein
, Thomas Klingebiel
, Sebastian Krümpelmann
, Melanie Metz
, Kerstin Schwenker (Co-Autor/-in)
, Karen Kranz
, Claudia Lanvers
, Joachim Boos

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

13 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	10
Fachzeitschrift	ANTI-CANCER DRUGS
Jahrgang	13
Ausgabenummer	1
DOIs	https://doi.org/10.1097/00001813-200201000-00012
Publikationsstatus	Veröffentlicht - 2002

Zugriff auf Dokument

10.1097/00001813-200201000-00012

Dieses zitieren

@article{d1296be287424784a0ef052faa4e9d60,

title = "Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens.",

keywords = "BONE-MARROW TRANSPLANTATION, UNBOUND ETOPOSIDE, PEDIATRIC-PATIENTS, PROTEIN-BINDING, CANCER-PATIENTS, ORAL ETOPOSIDE, PHASE-I, INFUSION, VP-16, TOXICITY",

author = "Gudrun W{\"u}rthwein and Thomas Klingebiel and Sebastian Kr{\"u}mpelmann and Melanie Metz and Kerstin Schwenker and Karen Kranz and Claudia Lanvers and Joachim Boos",

year = "2002",

doi = "10.1097/00001813-200201000-00012",

language = "English",

volume = "13",

pages = "10",

journal = "ANTI-CANCER DRUGS",

issn = "0959-4973",

publisher = "Lippincott Williams \& Wilkins ",

number = "1",

}

TY - JOUR

T1 - Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens.

AU - Würthwein, Gudrun

AU - Klingebiel, Thomas

AU - Krümpelmann, Sebastian

AU - Metz, Melanie

AU - Schwenker, Kerstin

AU - Kranz, Karen

AU - Lanvers, Claudia

AU - Boos, Joachim

PY - 2002

Y1 - 2002

KW - BONE-MARROW TRANSPLANTATION

KW - UNBOUND ETOPOSIDE

KW - PEDIATRIC-PATIENTS

KW - PROTEIN-BINDING

KW - CANCER-PATIENTS

KW - ORAL ETOPOSIDE

KW - PHASE-I

KW - INFUSION

KW - VP-16

KW - TOXICITY

U2 - 10.1097/00001813-200201000-00012

DO - 10.1097/00001813-200201000-00012

M3 - Original Article

C2 - 11914647

SN - 0959-4973

VL - 13

SP - 10

JO - ANTI-CANCER DRUGS

JF - ANTI-CANCER DRUGS

IS - 1

ER -